Position in ENGN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$827,060
+$596,903 QoQ
Shares Held
478,070
+1314.5% QoQ
Ownership
0.714%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#19
of 60 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ENGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Quadrature Capital Ltd holds $193,470,778 across 154 Biotechnology names. ENGN ranks #38 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
49,073 | $30,598,978 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
46,945 | $23,318,989 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
92,717 | $17,364,039 | |
| 4 | ASND |
Ascendis Pharma A/S
|
40,845 | $10,894,178 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
29,203 | $8,321,978 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
22,653 | $6,819,232 | |
| 7 | BNTX |
BioNTech SE
|
67,965 | $6,324,143 | |
| 8 | INSM |
INSMED Inc
|
48,355 | $5,155,610 |
All Filings in ENGN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $827,060 | 478,070 | Shares | Other | 2026-08-07 | |
| 2026-03-31 | $230,157 | 33,797 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $438,704 | 48,583 | Shares | Other | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||